
Nippon India Innovation Fund(G)-Direct Plan
+13.88%
3Y annualised
+13.88%
3Y annualised
+0.80% 1D
Expert Rating Locked 🔒
Subscribe to unlock the ratings
- Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- Mattis eget etiam curabitur a cras malesuada pulvinar.
Buy, Hold or Sell?
Unlock our SEBI-RIA verdict on this fund.

NAV : 17 Sep 2026
₹15.36
Min. SIP amount
₹100
Fund size (AUM)
3107 Cr
Expense ratio
0.62%
Launched on
28 Aug 2023
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
NAV : 17 Sep 2026
₹15.36
Min. SIP amount
₹100
Fund size (AUM)
3107 Cr
Expense ratio
0.62%
Launched on
28 Aug 2023
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
SIP Calculator + Returns
Monthly investment
₹8,000
Stock Allocation
Fund Composition
Large Cap
42.69%
Mid Cap
31.69%
Small Cap
22.37%
Others
3.25%
Sector Allocation
Retailing
18.09%
It
13.77%
Automobile & Ancillaries
13.16%
Domestic Equities
6.95%
Healthcare
6.94%
Capital Goods
6.01%
Bank
4.85%
Fmcg
4.80%
Others
25.43%
Minimum investments
Returns vs rankings
Exit load, stamp duty and tax
Exit load
1% on or before 1Y, Nil after 1Y
No exit load after holding period
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within less than 1 year, returns are taxed as per your Income Tax slab. If you redeem after more than 1 year, returns are taxed at 12.5%.
Fund management
Vinay Sharma
Present
Rishit Parikh
Present
Similar/Peer Fund Comparison
ICICI Pru Strategic Metal and Energy Equity FoF(G)-Direct Plan
HDFC Pharma and Healthcare Fund(G)-Direct Plan
Kotak Healthcare Fund(G)-Direct Plan
Motilal Oswal Active Momentum Fund(G)-Direct Plan
PGIM India Healthcare Fund(G)-Direct Plan
SBI Automotive Opportunities Fund(G)-Direct Plan
WOC Pharma and Healthcare Fund(G)-Direct Plan
ICICI Pru US Bluechip Equity Fund(G)-Direct Plan
FAQs
B. Premium Advisory - Everything in Basic, plus dedicated 1:1 expert calls, deeper portfolio reviews, personalised reports, and priority support to help you make confident, well-guided investment decisions.
